Advertisement
Organisation › Details
Scil Proteins GmbH
Scil Proteins is a biopharmaceutical company discovering and developing Affilin® molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. Affilin® molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin to form highly stable molecules with strong binding specificity and low immunogenicity. Scil Proteins' discovery platform is a fully patent protected screening technology for the identification of target-specific Affilin® molecules using advanced selection systems. Scil Proteins has generated a pipeline of Affilin® therapeutics targeting cancer and other therapeutic areas. It also offers the technology to the industry for collaborative discovery and development partnerships. With a longstanding expertise in protein production and development, Scil Proteins also offers GMP contract biomanufacturing and process development to biotech and pharma companies. Scil Proteins is a well-established private company located in Halle, Germany. *
Start | 1999-01-01 established | |
End | 2017-02-03 renamed | |
Group | UV-Cap (Vetter family office) (Group) | |
Today | Navigo Proteins GmbH | |
Successor | Navigo Proteins GmbH | |
Industry | contract manufacturing (biologicals) | |
Industry 2 | diagnostics (medical/biological) | |
Person | Fiedler, Ulrike (Coral BioNet 2000– Managing Director of Scil Proteins) | |
Person 2 | Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) | |
Region | Halle (Saale) | |
Country | Germany | |
Street | 1 Heinrich-Damerow-Str. | |
City | 06120 Halle (Saale) | |
Tel | +49-345-2799-6330 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2011-02-18) |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
More documents for UV-Cap (Vetter family office) (Group)
- [1] Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona....
- [2] Navigo Proteins GmbH. (9/26/22). "Press Release: Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19". Halle (Saale)....
- [3] UV-Cap GmbH & Co. KG. (2/3/17). "Press Release: UV-Cap GmbH & Co KG Acquires Scil Proteins GmbH. Scil Proteins GmbH Becomes Navigo Proteins GmbH". Halle (Saale)....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top